Lack of correlation between CYP2A6 genotype and smoking habits

被引：0
|
作者：
Schulz, TG
Ruhnau, P
Müller, M
Bünger, J
Elliehausen, HJ
Hallier, E
机构：
[1] Univ Gottingen, Dept Occupat Hlth & Social Med, D-37073 Gottingen, Germany
[2] Bau BG Hannover, Arbeitsmed Dienst, D-30519 Hannover, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2001年 / 363卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
657
引用
收藏
页码：R168 / R168
页数：1
相关论文
共 50 条
  • [41] Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy
    Malaiyandi, V
    Lerman, C
    Benowitz, NL
    Jepson, C
    Patterson, F
    Tyndale, RF
    MOLECULAR PSYCHIATRY, 2006, 11 (04) : 400 - 409
  • [42] A pilot study characterizing two novel CYP2A6 alleles, CYP2A6*7 and CYP2A6*8, in vivo.
    Xu, C
    Rao, Y
    Xu, B
    Hoffmann, E
    Sellers, EM
    Tyndale, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P35 - P35
  • [43] Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy
    V Malaiyandi
    C Lerman
    N L Benowitz
    C Jepson
    F Patterson
    R F Tyndale
    Molecular Psychiatry, 2006, 11 : 400 - 409
  • [44] Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C
    Ariyoshi, N
    Takahashi, Y
    Miyamoto, M
    Umetsu, Y
    Daigo, S
    Tateishi, T
    Kobayashi, S
    Mizorogi, Y
    Loriot, MA
    Stücker, I
    Beaune, P
    Kinoshita, M
    Kamataki, T
    PHARMACOGENETICS, 2000, 10 (08): : 687 - 693
  • [45] Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways
    Liu, Tao
    Chen, Wei-Qing
    David, Sean P.
    Tyndale, Rachel F.
    Wang, Hui
    Chen, Yu-Ming
    Yu, Xue-Qing
    Chen, Wei
    Zhou, Qian
    Ling, Wen-Hua
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (06) : 961 - 967
  • [46] Inhibitory Potency of 8-Methoxypsoralen on Cytochrome P450 2A6 (CYP2A6) Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22: Differential Susceptibility Due to Different Sequence Locations of the Mutations
    Tiong, Kai Hung
    Yunus, Nafees Ahemad Mohammed
    Yiap, Beow Chin
    Tan, Eng Lai
    Ismail, Rusli
    Ong, Chin Eng
    PLOS ONE, 2014, 9 (01):
  • [47] Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence
    Malaiyandi, V
    Sellers, EM
    Tyndale, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (03) : 145 - 158
  • [48] CYP2A6 phenotype in a Spanish population:: Influence of gender, age and smoking
    Carcas de Benavides, C.
    Fanlo Villacampa, A.
    Soriano Guillén, A.
    Vicente Romero, J.
    Arenaz Villalba, I.
    Mayayo Dehesa, E.
    Sinués Porta, B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 53 - 54
  • [49] Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers
    Ho, M. K.
    Mwenifumbo, J. C.
    Al Koudsi, N.
    Okuyemi, K. S.
    Ahluwalia, J. S.
    Benowitz, N. L.
    Tyndale, R. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (06) : 635 - 643
  • [50] A CYP2A6 haplotype explains a substantial part of CYP2A6 phenotype variation in caucasians
    Haberl, M
    Weil, R
    Fuss, C
    Zanger, UM
    Kerb, R
    Wojnowski, L
    DRUG METABOLISM REVIEWS, 2003, 35 : 67 - 67
12345